Athos Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-22,139
Closed -$2.15M 45
2019
Q3
$2.15M Buy
22,139
+927
+4% +$92.8K 2.11% 13
2019
Q2
$2.17M Buy
+21,212
New +$2.29M 0.96% 21

Athos Capital's ONCE Position: Q4 2019 in Review

Athos Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 22,139 shares — an estimated $2.15M sold.

Athos Capital first reported a position in ONCE in Q2 2019 and held it in 2 quarters. The position peaked at $2.17M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Athos Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Athos Capital sold 22,139 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.15M.
  • Athos Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • Athos Capital's Spark Therapeutics, Inc. Common Stock position peaked at $2.17M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Athos Capital's 13F filing for Q4 2019, filed 11 Feb 2020.